Suppression of bladder hyperreflexia by intravesical resiniferatoxin [8]

Lancet

Volumn 350, Issue 9078, 1997, Pages 640-641

  Cruz, Francisco ^a   Guimarães, Miguel ^b   Silva, Carlos ^b   Reis, Mário ^b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; RESINIFERATOXIN;

BLADDER CATHETERIZATION; BLADDER DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; HYPERREFLEXIA; INTRAVESICAL DRUG ADMINISTRATION; LETTER; NERVE FIBER C; PAIN; PRIORITY JOURNAL; PRURITUS; SENSORY NERVE; URINE INCONTINENCE;

EID: 0342437490     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)63330-2     Document Type: Article

References (5)

1. De Groat WC, Kawatani M, Hisamitsu T, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; 30: 571-78.
2. Szallasi A, Blumberg PM. Vanilloid receptors: new insights enhance potential as therapeutic target. Pain 1996; 68: 195-208.
3. Fowler CA, Jewkes D, McDonald WI, Lynn B, de Groat WC. Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 1992; 339: 1239.
4. Fowler CA, Beck RO, Gerrard S, Betts CD, Fowler CG. Intravesical capsaicin for treatment of detrusor hyperreflexia. J Neurol Neurosurg Psychiatry 1994; 57: 169-73.
5. Cruz F, Guimarães M, Silva C, Rio ME, Coimbra A, Reis M. Desensitization of bladder sensory fibres by intravesical capsaicin has long-lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 1997; 157: 585-89.